Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Cytokinetics Inc CYTK

Healthcare Biotechnology
Cytokinetics, Incorporated is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised. The Company specializes in muscle biology and the mechanics of muscle... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CYTK)

Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress

GlobeNewswire 13 days ago

Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session

GlobeNewswire April 5, 2024

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire April 2, 2024

Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire April 1, 2024

Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session

GlobeNewswire March 25, 2024

Cytokinetics to Participate in March Investor Conferences

GlobeNewswire March 4, 2024

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire March 1, 2024

Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day

GlobeNewswire February 29, 2024

Cytokinetics, The Mended Hearts, Inc. and WomenHeart Announce Launch of New Initiative to Increase Engagement in Cardiovascular Clinical Trials

GlobeNewswire February 28, 2024
View More News ››

Opinion & Analysis (NDAQ:CYTK)

The inflammatory disease marketplace meets the drug pricing controversy: FBR & Co.'s Vernon Bernardino

The Life Sciences Report October 22, 2015
View More Opinion ››

Bullboard Posts (NDAQ:CYTK)

Cytokinetics to Participate in March Investor Conferences |

NEWS: $CYTK Cytokinetics to Participate in March Investor Conferences | BenzingaSOUTH SAN FRANCISCO, Calif., March 04, 2024 (GLOBE...
whytestocks - March 4, 2024

5 BIOTECH STOCKS WITH MAJOR UPCOMING CATALYSTS

$CYTK $ADGI $PHAT $AGIO $ICPT   Clinical-Stage companies offer an exciting investment opportunity with massive upside potential...
AviseAnalytics - February 8, 2022

Good news

Good news for CYTK and Reldesemtiv. Hopefully a rise in the price next week. What do you think ?
andre171 - June 16, 2018

ill ask the board a question....

Since I know people are reading lol.....will cytk continue the uptrend. .....is this a sign that positive results are imminent. ...does...
lovetheoilpatch - April 19, 2014

wtf .....action about to start and nobodys on this board????

Whats goin on here .....25 dollar target and no action on this board
lovetheoilpatch - April 19, 2014
View more Bullboard ››

Forsys Metals Corp

Forsys Metals Corp

Forsys Metals Corp. is a Canada-based company, which is engaged in the business of acquiring, exploring and developing ...
View More »